Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta-analyses.
Marie Louise Roed RasmussenMaria D'SouzaDivan Gabriel TopalJosefine GradmanDorte Ancher LarsenBettina Behrmann LehrmannHenrik Fomsgaard KjaerKessel LineYousif SubhiPublished in: Acta ophthalmologica (2022)
To determine the prevalence of allergic sensitization in patients with vernal keratoconjunctivitis (VKC) and to provide an overview of published studies on this topic. We systematically searched 11 literature databases on 24 May 2021, for studies with cross-sectional data on the prevalence of positive allergy tests in patients with VKC. Our main outcome of interest was the prevalence of allergic sensitization and the allergens involved. Prevalence meta-analyses were made to provide summary estimates. We identified 33 eligible studies for qualitative review with 2122 patients with VKC. Studies were predominantly based on patients seen in ophthalmology clinics. Overall, studies reported that the most prevalent positive allergen tests were the inhaled allergens house dust mites and pollen. Twenty-nine studies were eligible for the quantitative analysis. Here, we calculated the prevalence of allergen-positive patients to 57.7% (95% confidence interval: 52.5%-62.8%). Subgroup analyses of pooled estimates on sensitization based on specific testing methods found prevalence estimates of 51.4% for conjunctival provocation test, 68.7% for total tear IgE, 58.9% for specific tear IgE, and 58.2% for skin prick test. The prevalence of allergic sensitization in patients with VKC is 57.7%, and mostly towards inhaled allergens. The most frequent positive allergens are house dust mites and pollen. Identifying possible clinically relevant allergens provide information that may aid in managing VKC, such as environmental allergy-avoidance or allergy-specific treatment.
Keyphrases
- risk factors
- systematic review
- meta analyses
- cross sectional
- end stage renal disease
- newly diagnosed
- case control
- ejection fraction
- randomized controlled trial
- prognostic factors
- primary care
- atopic dermatitis
- healthcare
- peritoneal dialysis
- cystic fibrosis
- clinical trial
- allergic rhinitis
- deep learning
- risk assessment
- climate change
- artificial intelligence
- health information
- drinking water
- phase iii
- health risk assessment